Back

Targeting Interleukin-1 in cardiovascular disease prevention.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Inflammation: a new target in cardiovascular disease prevention Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Wolfgang Koenig

TUM Universitätsklinikum, German Heart Center, Munich (Germany)

3 More presentations in this session

Presentation thumbnail
Autoimmune diseases and cardiovascular risk.
Professor N. Sattar (Glasgow, GB)
Slides Video
Presentation thumbnail
Targeting Interleukin-6 signalling in cardiovascular disease prevention.
Associate Professor B. Gigante (Stockholm, SE)
Slides Video
Presentation thumbnail
Inflammation: a new target in cardiovascular disease prevention – discussion.
Video

Access the full session

Session thumbnail
Inflammation: a new target in cardiovascular disease prevention
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Session
Inflammation: the next target in atherosclerotic cardiovascular disease care?
thumbnail
Congress Presentation
Interleukin-6 inclusion adds value to the SMART risk score for prediction of cardiovascular death in patients with established ASCVD
thumbnail
Congress Presentation
Direct IL-6 inhibition prevents arterial thrombosis by reducing collagen-mediated platelets activation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources